Skip to main content
. Author manuscript; available in PMC: 2016 Jun 5.
Published in final edited form as: Chem Biol Interact. 2014 Nov 21;234:154–161. doi: 10.1016/j.cbi.2014.11.010

Figure 4.

Figure 4

Doxorubicinol formation in Gclm −/− and Gclm +/+ hepatocytes. (A) Representative HPLC chromatograms of doxorubicinol formation in Gclm −/− (top panel) and Gclm +/+ (bottom panel) hepatocytes. (B) Quantification by HPLC of doxorubicinol formation (area units, AU) in hepatocytes and (C) media taken from doxorubicin treatments; n=12 for each treatment. *** indicates p < 0.001 for Student’s t-test relative to wild-type for each dose.